<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Otsuka Holdings Co., Ltd. Otsuka Group News RSS</title>
    <link>http://www.otsuka.com</link>
    <description>Otsuka Holdings Co., Ltd. Otsuka Group News RSS</description>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="http://www.otsuka.com/en/group_news/rss.php" type="application/rss+xml" rel="self"/>
    <pubDate>Thu, 05 Nov 2026 09:00:00 +0900</pubDate>
    <lastBuildDate>Thu, 05 Nov 2026 09:00:00 +0900</lastBuildDate>
    <ttl>60</ttl>
    <item>
      <title>Taiho Pharmaceutical and Taiho Oncology to Present Data from AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia at the 68th ASH Annual Meeting and Exposition</title>
      <link>https://www.taiho.co.jp/en/release/2026/20261105.html</link>
      <description/>
      <pubDate>Thu, 05 Nov 2026 09:00:00 +0900</pubDate>
      <news_id>1641</news_id>
    </item>
    <item>
      <title>Paradise uRDN System Demonstrates 19.5 mmHg Blood Pressure Reduction at 12 Months, with Durability Through 4 Years (Link to Recor website)</title>
      <link>https://www.recormedical.com/paradise-urdn-system-demonstrates-19-5-mmhg-blood-pressure-reduction-at-12-months-with-durability-through-4-years/</link>
      <description/>
      <pubDate>Wed, 04 Nov 2026 09:00:00 +0900</pubDate>
      <news_id>1640</news_id>
    </item>
    <item>
      <title>Otsuka Pharmaceutical Factory launches “HINEX E-Gel 1.5,” a concentrated liquid diet with a caloric density of 1.5 kcal/mL designed with intake volume and fluid restriction in mind</title>
      <link>https://www.otsukakj.jp/en/news_release/20261027.html</link>
      <description/>
      <pubDate>Tue, 27 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1638</news_id>
    </item>
    <item>
      <title>Otsuka BioVentures Begins Strategic Equity Investments</title>
      <link>https://www.otsuka.co.jp/en/company/newsreleases/2026/20261026_1.html</link>
      <description/>
      <pubDate>Mon, 26 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1639</news_id>
    </item>
    <item>
      <title>Otsuka Presents Landmark Final Phase 3 VISIONARY Results at ASN Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilized Kidney Function and Reduced Risk of Disease Progression and Kidney Failure, Redefining Treatment Paradigm in IgA Nephropathy</title>
      <link>https://www.otsuka.co.jp/en/company/newsreleases/2026/20261023_1.html</link>
      <description/>
      <pubDate>Fri, 23 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1636</news_id>
    </item>
    <item>
      <title>Taiho Pharmaceutical Installs New Solar Power Generation Facility at Tsukuba Drug Discovery Site to Accelerate Carbon Neutrality Initiatives</title>
      <link>https://www.taiho.co.jp/en/release/2026/20261022.html</link>
      <description/>
      <pubDate>Thu, 22 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1637</news_id>
    </item>
    <item>
      <title>Zipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS Metastases　（Link to Taiho Oncology website）</title>
      <link>https://www.taihooncology.com/us/news/zipalertinib-demonstrates-clinically-meaningful-intracranial-antitumor-activity-in-patients-with-nsclc-with-egfr-exon-20-insertion-or-uncommon-egfr-mutations-and-active-cns-metastases/</link>
      <description/>
      <pubDate>Mon, 19 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1635</news_id>
    </item>
    <item>
      <title>Otsuka Foods to Revise Price of CRYSTAL GEYSER Product New Price to Take Effect with Deliveries as of January 1, 2027</title>
      <link>https://www.otsukafoods.co.jp/en/news/20261016.html</link>
      <description/>
      <pubDate>Fri, 16 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1633</news_id>
    </item>
    <item>
      <title>TIME Names Recor Medical’s Paradise Ultrasound Renal Denervation System one of the Best Inventions of 2026 (Link to Recor website)</title>
      <link>https://www.recormedical.com/time-names-recor-medical-paradise-ultrasound-rendal-denervation-system-one-of-the-best-inventions-of-2026/</link>
      <description/>
      <pubDate>Fri, 16 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1634</news_id>
    </item>
    <item>
      <title>Paradise Ultrasound Renal Denervation System Receives Good Design Award 2026</title>
      <link>https://www.omd.otsuka.com/en/news/newsreleases/20261015.php</link>
      <description/>
      <pubDate>Thu, 15 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1632</news_id>
    </item>
  </channel>
</rss>
